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Abstract— A number of Thrombectomy devices using a variety 
of methods have now been developed to facilitate clot removal. 
We present research involving one such experimental device 
recently developed in the UK, called a 'GP' Thrombus-
Aspiration-Device (GPTAD). This device has the potential to 
bring about the extraction of a thrombus. Although the device 
is at a relatively early stage of development, the results look 
encouraging. We present an analysis of modelling this device 
using modelling techniques. Such modelling appears to be 
highly effective in simulating the device under a variety of 
conditions with a view to assisting in the optimisation of the 
GPTAD. The aim of this simulation model is to obtain the 
minimum pressure necessary to extract the clot and to verify 
that, both the pressure and the time required to complete the 
clot extraction are reasonable for use in clinical situations, and 
are consistent with any experimentally obtained data. 
Keywords- Biomedical engineering, Thrombectomy Device, 
Simulation techniques. 
I. INTRODUCTION 
Peripheral vascular disease (PVD) affects some 12 
million people in the United States alone [1]. The prevalence 
of peripheral vascular disease in people aged over 55 years in 
the UK is 10%-25% -however- this figure rises it with age. 
Although 70%-80% of affected patients are asymptomatic, 
only a relatively small number of these ever require 
revascularisation procedures or amputation [2]. Chiefly PVD 
is caused by atherosclerosis [3], and it is believed by some 
that PVD may be underdiagnosed [4]. Major risk factors for 
peripheral arterial disease include cigarette smoking, 
diabetes mellitus, hypertension, and hyperlipidemia. 
The patient often experiences symptoms that include 
colour changes to the lower limbs and feet, intermittent 
claudication (pain commonly in the calf, thigh or buttock on 
walking a relatively short distance), and a burning sensation 
in the legs and feet at night in bed that is commonly relieved 
by hanging the legs over the side of the. It is also 
characterised by an abnormal ankle brachial index 
measurement [5]. Measurements of so-called ankle brachial 
pressure index (ABPI/ABI) using Doppler ultrasonography 
may be used in the diagnosis of peripheral vascular disease, 
in conjunction with a physical examination of the patient. 
ABPI/ABI is a measure of the decrease in blood pressure in 
the arteries supplying the legs. A fall in ABPI (less than 0,9) 
is consistent with PVD. Values of ABPI below 0,8 indicate 
moderate disease and below 0,5 severe disease. However, it 
is possible for other conditions to give false readings e.g. 
conditions which stiffen the vessel walls (such as 
calcifications in the vessel wall that occur in e.g. chronic 
diabetes). Other tests that may be used include magnetic 
resonance angiography. Cigarette smoking, diabetes 
mellitus, hypertension, hyperlipidemia, age greater than 40 
years, all lead to an increased risk of developing PVD. 
Smoking is the most important risk factor and perhaps 
carries the greatest risk of developing PVD [6], and cessation 
of smoking appears to reduce the progression of PVD [7], 
II. TREATMENTS FOR PVD 
Treatments include life style modification, exercise 
training, and drug therapy, angioplasty, bypass graft, and 
amputation [3]. 
Drug therapies for peripheral arterial disease include 
aspirin (with or without dipyridamole), and clopidogrel. 
Good glycaemic control appears to decrease the incidence of 
intermittent claudication or critical limb ischemia [8]. 
Furthermore the United Kingdom Prospective Diabetes 
Study (UKPDS) [9] indicated that controlling hyperglycemia 
in PVD may decrease the rates of cardiovascular disease and 
myocardial infarction, and also reduce the occurrence of 
PVD. Conservative measures include stopping smoking. 
Regular exercise often helps open so-called collateral 
vessels-alternative small vessels (collateral flow) through 
which blood can flow. Medications including the use of 
statins assist further. Statins reduce cholesterol levels, and 
aspirin reduces the chance of blood clot formation. 
Angioplasty (PTA or percutaneous transluminal angioplasty) 
may also be performed, to widen affected vessels. Excision 
of the plaque may also be undertaken, which involves 
scraping the plaque off of the inside of the vessel wall. 
Bypass grafts may be used to bypass a stenosed area of the 
vessel. The latter may be undertaken using either the 
saphenous vein, or an artificial materials. Sympathectomy 
may be used to denervate nerves that cause vasoconstriction 
of arteries, thus bringing about vasodilation of the vessel. 
Amputation may be performed as a last resort to prevent the 
spread of infection in cases where gangarene has ensued. 
A blood clot may sometimes develop at the site of the 
atheromatous plaque in the affected limb. In such instances 
attempts can be made to dissolve the clot using a 
thrombolytic agent such as tPA or heparin. Removal of the 
clot may also be undertaken by an embolectomy catheter. 
III. GPATD STRUCTURE 
Recently a thrombus aspiration device called the GPTAD 
has been invented by Pearce and Perkinson [10][11]. In the 
sections below we have used Bond Graph modelling to 
model the removal of such a blood clot in the lower limb. 
The aim of such modelling is to show how bond graph 
modelling may possibly be used to optimsize the GPTAD as 
a device (figure 1) for a potential treatment for the removal 
of blood clots that arise during PVD. 
The GPTAD device assembly involves using a vacuum 
pump (that provides the suction pressure for removal of the 
clot), joined to a very long catheter (-100 cm long and ~1,5-
2,0 mm in diameter); the 'GP' device is located at the end of 
this catheter (same diameter and a length of 20 mm). This 
GPTAD is introduced into the popliteal artery via a 
transfemoral approach to the lower limb such that the 
GPTAD is positioned in close proximity to the occluding 
blood clot, at a distance of approximately 3 mm from it. 
Then the suction begins until the clot is extracted. The clot 
crosses the 3 mm that separates it from the GPTAD and 
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Figure 1. Schematic view of the GPTAD 
It is currently being developed as a potential thrombus 
aspiration device through a series of in-vitro studies. This 
device has the potential to be used in relatively small 
arteries. It has no moving parts and therefore should reduce 
the risk of breakage in a vessel. Since it does not touch the 
clot itself it should also reduce the risk of clot disruption and 
downstream embolisation. Thrombectomy is achieved by 
aspiration through a catheter in which the 'GPTAD' device 
is embedded. The internal surface has been mathematically 
optimized. It is also potentially associated with low forces at 
the periphery of the device which may therefore reduce the 
risk of arterial collapse during aspiration of the clot [12]. 
IV. MODELLING THE GPTAD DEVICE 
The objective of this study is to introduce a model that 
can be used investigate and assist in the final design of the 
GPTASD. We investigate the potential performance of the 
GPTAD device under different conditions of blood flow, size 
of blood clot, in a given vessel. The method chosen for the 
representation and simulation of the GPTAD in this instance 
is the Bond Graph technique [13]. Some models have been 
modeled by using this technique [14][15] and its choice is 
based on the fact that this technique allows assimilating the 
model to an electric circuit made up of resistances, 
capacitances and inductances. Therefore, it is possible to 
obtain the results in a simple way by evaluating flows and 
efforts that join and connect the components of the model. 
To obtain the simulation of the model, Bondin © software 
will be used [16]. This program allows obtaining the 
evolution of the characteristic parameters of the model as 
well as letting them be compared. 
To generate the correct model, it was necessary to 
analyze the resistances that appear when fluid and blood clot 
flow into the catheter, the inertances due to mass of fluid, 
and finally the compressibility that the blood and artery are 
subjected to [17]. 
A. Resistances 
Linear load loss is due to the friction between the liquid 
particles and the artery walls. To simplify, only linear load 
losses are taken into account. If we suppose that the artery is 
composed of successive horizontal pipes of constant cross 
section in each section, the load loss is reduced to a pressure 
loss as the fluid advances along the artery, the loss being 
progressive and proportional to the length of the artery. If we 
assume that the blood flow is laminar due to the Reynolds 
number being approximately 1.000 (Re<2.200), the equation 
that governs the behaviour in the catheter can be determined 
by the following expression: 
where 'n' is the dynamic viscosity of the blood flow, 'L' the 
length of the catheter section and 'D' its diameter. 
Some studies show that in diseased arteries viscosity 
bloodstream varies, increasing its value but for this first 
approximation we used a normal value of 0,0035 Pas. 
Later in the model, the 'GPTAD' device (see figure 1) is 
positioned near the clot. The resistance of the blood flow 
can be represented by the same eq. (1) with the 
corresponding values. 
Due to the artery being located near the end of the 
GPTAD, it is necessary to consider the transition between 
both elements as a secondary load loss caused by the 
difference in diameter of the 'GP' device and the artery 
respectively and the subsequent variations in flow. These 
load losses can be represented as a resistance and can be 
calculated with the following expression: 
where 'p ' is the blood density (1.060 kg/m3), 'Q' is the flow 
which circulates in the section between the end of the 'GP' 
device and the artery, and the diameter 'D' is the mean value 
between the cylinder and the artery. 
In addition, the load loss coefficient '£' is a 
dimensionless parameter that quantifies the loss produced 
and depends on the geometry of the deflecting nozzle; since 
this is a narrowing, this value is 0,43-0,45. 
Finally, the friction between the clot and the arterial wall 
creates another resistance factor. The value of this parameter 
must be variable depending on whether the clot has begun its 
movement (dynamic friction) or before it has begun to move 
(static friction) during the clot extraction procedure. When 
the clot begins to move the friction decreases considerably. 
This value is obtained from the Stokes equation and can be 
given a value of 2,5 TO"6 Ns/m for the static friction and an 
order of magnitude lower than for the dynamic friction. The 
transition between both values marks the beginning or end of 
the clot movement. 
B. Inertances 
The flow inertia to be overcome in the movement from 
clot to pump must be taken into account and it can be 
modelled with the flow and the section. Considering a 
section with circular geometry, we can assume the blood 
inertance with the following expression: 
where 'p ' is the blood density, 'L' the length of the same 
artery section done when resistances were studied, and 'D' 
its diameter. To obtain correct values, it's necessary to apply 
the length and sections depending on different areas of the 
(catheter, the GP device or the space between the GPTAD 
and clot). 
In addition to the previous inertance inserted, the model 
must have an inertance that represents the mass of the clot 
(0,6-5,5 gr). 
C. Compresibilities 
To complete the model, the blood compressibility must 
be included with the previous values in the model. In fact, it 
acts as a compliance producing a decrease in volume when 
the pressure required for compression is increased. This 
behaviour is dependent on the Bulk's blood coefficient (B, 
with a value 2,2T09 N/m) and section of the artery. If we 
assume a circular geometry, it can be defined as a 
capacitance of K value: 
where 'L' is the total length of the catheter, GPTAD and 
GP-clot distance. 
In addition, it is necessary to insert the compressibility of 
the length of artery that appears between the GP device and 
the clot, in line with its Young's modulus: 
where 'E' is its Young's modulus (2,8T09 N/m), 'h' is the 
thickness of the artery (0,1 mm), 'V0' is the artery initial 
volume and 'r0' is the artery initial radius. 
In addition to resistance, inertance and compressibility, 
the pump creates the necessary pressure to carry out the 
extraction, and is positioned at the other end of the vatheter 
that does not contain the GPTAD. In the model, it is 
represented by a variable pressure source whose value will 
increase from zero to a non-determined value suitable for 
carrying out the operation of clot removal and will be 
obtained from the optimization of the developed model. The 
time taken to reach the maximum value of pressure has been 
obtained from experiment and is about 2-3 sec, after which 
time the pressure provided by the pump remains constant. 
In order to calculate the effect of the entire catheter in 
this model, (due to the length), it was partitioned in identical 
sections (ten sections) and was represented by ten sub-
models that include the previous described parameters. 
Once all this was defined in the model, it was necessary 
to change from the hydraulics to mechanics domain before 
considering the clot element, to be able to evaluate the clot 
movement and effort involved in clot extraction taking into 
account the physical friction between the clot and the artery. 
This domain change is carried out by a Transformer (TF) 
element. To calculate the value of the coefficient defining 
this element, the change in the definition of the flow before 
and after this element is evaluated. Before the transformer, 
the flow is in the hydraulics domain, while after, it is in the 
mechanics domain. The coefficient was determined by 
evaluating the required change between both domains. 
r =
 /A=K-R2 (fi) 
where 'R' is the artery radius. 
Finally, in figure 2 it's possible see the full model of the 
complete GPTAD, in which we can see the order of the 
different elements. To formulate the corresponding equations 
from the different described phenomena, it was necessary to 
assume that the flow after and before resistances and 
inertances are the same; nevertheless, with this assumption in 
respect of after and before compliances the pressures are 
similar. 
















Figure 2. Full model of the GPTAD. 
The main objective of the development of this simulation 
model will be to obtain the minimum pressure required to 
perform the extraction and to check that this pressure 
together with the time required to complete the operation are 
reasonable are within acceptable clinical boundaries for 
eventual potential use of the GPTAD on a patient, and are 
similar to experimentally obtained data. These studies and 
confirmations will allow optimization of the device to assist 
in possible future use of this device in patients with 
thrombosis. 
V. APPLICATION TO THE POPLITEAL ARTERY. 
By using the previous phenomena, it has been simulated 
the extraction of a blood clot from the popliteal posterior 
artery. For the present study it has been considered a 
diameter of 1,5 mm for the catheter and the 'GP' and, for the 
artery a diameter of 4mm. 
Simulations of this model have been undertaken for 
several lengths of the clot, from 10 mm to 90 mm. To 
simulate each length, we considered that the clot mass is 
dependent from on geometry (volume). To simplify the 
problem, the geometry that has been considered assumed that 
the clot and the plaque together are a cylinder each 
occupying 50 % of the diameter of the popliteal artery, as 
can be seen in figure 3. 
Removal Clot 
Figure 3. Schematic view of plaque and removal clot in PVD. 
In this model, the clot is a half cylindrically-shaped 
element of [1-9] cm in length, and of a mass that falls 
between [0,6-5,5] gram. Due to the difference in diameter 
between the clot and artery-plaque (a constriction of flow in 
the artery leads to the formation of a clot), the clot becomes 
attached to the artery wall by a force of adhesion, that needs 
to be overcome in order to facilitate clot movement for 
removal. In addition, the relative movement between the clot 
and the artery presents static and dynamic friction, which 
needs to be taken into account. If a correct approximation to 
reality is to be achieved all these phenomena, as well as the 
circumstances restricting clot movement, need to be 
considered. 
The suction pressure that generates the pump actuates in 
both elements: the clot and the plaque. To obtain the 
displacement of the clot we have assumed that its surface is 
half of the artery's section. Moreover, when different masses 
are being considered, the surface in contact with the artery 
wall and the plaque, changes. As already stated, the 
phenomenon preventing clot movement is the difference in 
diameter between the clot and the artery-plaque where it is 
located. We have assumed that the force of attachment of the 
clot to the artery wall is -0,0 IN, based on a simple 
calculation involving density, volume and pressure, and 
assuming a spherical clot (in the absence of any experimental 
data or values available in the literature). Clot movement 
therefore begins when this force is equal to 0,01 N. In our 
model we have assumed that this force of 0,0 IN applies 
equally well to any other clot geometry, and it has been 
included as a superficial stress parameter. The superficial 
stress can be calculated as the force that is necessary to 
overcome movement divided by the length in contact with 
the wall artery and the plaque. This line of contact is in the 





Figure 4. Suction force over clot and superficial tension. 
In order to decide when to begin the movement of the 
obstructive element, firstly we need to insert a compliance 
into the model to measure the force supported by the 
beginning of the clot and its deformation. To obtain the value 
of this compliance the phenomenon of surface tension must 
be taken into account, since it is this that joins the clot to the 
artery. This surface tension 'y' comes about from the 
attraction forces between molecules and is defined as force 
by unit length T. If we take a sphere into the artery, the 
surface tension would act on the circumference of the contact 
between the clot and the artery. If we take into account the 
value of the length of contact from the radius 'r' of the 
artery, the value for the surface tension can be obtained and, 
in turn, the value for the compliance coefficient as: 
K = y = F II (7) 
As stated above, the clot is between [1-9] cm long, which 
means it can be broken down into the union of several 
spheres, all with the same constant. Since over the whole 
surface of the clot there are forces of adhesion, to obtain a 
correct approximation it is necessary to consider the 
existence of a sphere for every 0,1 mm. This means that 
between 100 and 900 spheres would need to be included in 
the model. On the other hand, all the spheres must be located 
in parallel to obtain the resultant adhesive force, and since all 
the individual compliances are equal, the number of spheres 
depends on the length of the clot, i.e., the equivalent 
compliance for a 5 cm clot (500 spheres) can be obtained 
from the form appearing in the following expression: 
K„ F/l 0,525762 
500 
0,001052 N/m (8) 
To know when the force has been obtained in this 
equivalent compliance and, therefore, when the clot 
movement will begin, it is essential to calculate the 
displacement of the compliance when it is subjected to 0,01 
N through a typical compliance equation. Therefore, only 
when the compliance undergoes this displacement should the 
clot be able to move; less than this value would mean that the 
clot could not move. The clot has to traverse a displacement 
of 3 mm until it reaches to the end of the GPTAD. The time 
to complete this displacement with different pressures is the 
time that results from the modelling. 
VI. RESULTS 
Figure 5 shows the results for the modeling undertaken. 
Different lengths of clot were modelled (1 cm, 3 cm, 5 cm, 7 
cm and 9 cm) at different pressures (30 kPa, 40 kPa, 50 kPa, 
60 kPa and 70 kPa). 
In figure 5 results are shown, for each length of clot, 
together with the time when the clot begins to move until and 
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Figure 5. Time to end of the extraction Vs suction pressure. 
In considering the results of the modelling presented in 
figure 5, it can be seen that clots with a length between 1 cm 
to 3 cm, need relatively low suction pressures and short 
times for clot capture. However, clots with a size between 
5cm to 9cm show a bigger variation in the time involved 
with different pressures. 
For a clot of length 1cm, the times to complete the 
displacement are relatively low. So a low pressure could 
possibly be used to extract such a clot. 
For a clot of length 3cm the times taken for extraction are 
within the range [9-21] seconds. This range seems 
reasonable and we could conclude that a pressure of ~30 kPa 
could be enough to remove the clot in ~21 seconds. 
For clots of length between 5 cm to 9 cm the results 
indicate that the times required for removal are higher; for a 
5 cm clot this range is [14-36] seconds. A pressure of 50 kPa 
appears to remove the clot in a time of-21,5 seconds. 
We could therefore speculate that for a clot of length 7 
cm, a pressure of ~50 kPa or ~60 kPa may be required to 
remove the clot in ~24 seconds or ~28 seconds. However 
using a lower pressure it is possible to remove the clot, but 
the times are sharply increased. 
Finally for a clot of length 9 cm, the times are within the 
range [28-60] seconds. We could conclude that 28 seconds 
seems to be a reasonable time avoiding lengthening the 
operation of extracting the clot. 
The times that are calculated with this model show only 
the time necessary for the extraction of the clot once the 
'GP' is correctly situated. However to obtain the whole time 
to carry out the operation, it would be necessary to add on 
the time taken to situate the 'GP' in the artery and the time to 
take it out of the body. 
VII. CONCLUSIONS 
The simulation shows that pressures between [30-70] kPa 
seem to be enough to remove clots of differents sizes in a 
range within [4-60] seconds. No in-vitro data currently 
exists for this device in respect of its use in the leg to 
remove blood clots that arise during peripheral vascular 
disease, so no comparisons can yet be made between in-
vitro measurements using models and our Bond graph 
modelling. 
Moreover, analyzing the resistances in the catheter 
indicates that an important pressure loss takes place in the 
catheter joining the pump to the 'GP'. The values obtained 
could possibly be used to optimize its geometry. 
VIII. FUTURE WORKS 
Bond Graph mathematical modelling is now being 
implemented to model and simulate the coronary vessels of 
the heart. The analysis will involve the GPTAD in proximity 
to both athromatous plaques and blood clots, in coronary 
vessels which become blocked in myocardial infarction. 
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